Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Rheumatology Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Rheumatology Drugsmarket, defines the market attractiveness level of Rheumatology Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Rheumatology Drugs industry, describes the types of Rheumatology Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Rheumatology Drugs market and the development prospects and opportunities of Rheumatology Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Rheumatology Drugs market in Chapter 13.
By Player:
Takeda Pharmaceutical
Amgen
Bristol-Myers Squibb Company
Sanofi
AbbVie
Janssen Biotech
Merck and Co
Genentech
Novartis
Pfizer
By Type:
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others
By End-User:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Rheumatology Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Rheumatology Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Rheumatology Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Rheumatology Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Rheumatology Drugs Market Analysis and Outlook to 2022
-
7.1 Global Rheumatology Drugs Consumption (2017-2022)
-
7.2 United States Rheumatology Drugs Consumption (2017-2022)
-
7.3 Europe Rheumatology Drugs Consumption (2017-2022)
-
7.4 China Rheumatology Drugs Consumption (2017-2022)
-
7.5 Japan Rheumatology Drugs Consumption (2017-2022)
-
7.6 India Rheumatology Drugs Consumption (2017-2022)
-
7.7 South Korea Rheumatology Drugs Consumption (2017-2022)
8 Region and Country-wise Rheumatology Drugs Market Analysis and Outlook to 2028
-
8.1 Global Rheumatology Drugs Consumption Forecast (2022-2028)
-
8.2 United States Rheumatology Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Rheumatology Drugs Consumption Forecast (2022-2028)
-
8.4 China Rheumatology Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Rheumatology Drugs Consumption Forecast (2022-2028)
-
8.6 India Rheumatology Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Rheumatology Drugs Consumption Forecast (2022-2028)
9 Global Rheumatology Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Rheumatology Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Disease Modifying Anti-rheumatic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Nonsteroidal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Uric Acid Drugs Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Rheumatology Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)
10 Global Rheumatology Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Rheumatology Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Disease Modifying Anti-rheumatic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Nonsteroidal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Uric Acid Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Rheumatology Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
11 Global Rheumatology Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Rheumatology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Rheumatology Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Rheumatology Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Rheumatology Drugs Market Competitive Analysis
-
14.1 Takeda Pharmaceutical
-
14.1.1 Takeda Pharmaceutical Company Details
-
14.1.2 Takeda Pharmaceutical Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Pharmaceutical Rheumatology Drugs Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Rheumatology Drugs Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Rheumatology Drugs Product and Service
-
14.4 Sanofi
-
14.4.1 Sanofi Company Details
-
14.4.2 Sanofi Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Sanofi Rheumatology Drugs Product and Service
-
14.5 AbbVie
-
14.5.1 AbbVie Company Details
-
14.5.2 AbbVie Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 AbbVie Rheumatology Drugs Product and Service
-
14.6 Janssen Biotech
-
14.6.1 Janssen Biotech Company Details
-
14.6.2 Janssen Biotech Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Janssen Biotech Rheumatology Drugs Product and Service
-
14.7 Merck and Co
-
14.7.1 Merck and Co Company Details
-
14.7.2 Merck and Co Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck and Co Rheumatology Drugs Product and Service
-
14.8 Genentech
-
14.8.1 Genentech Company Details
-
14.8.2 Genentech Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Genentech Rheumatology Drugs Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Rheumatology Drugs Product and Service
-
14.10 Pfizer
-
14.10.1 Pfizer Company Details
-
14.10.2 Pfizer Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Pfizer Rheumatology Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Rheumatology Drugs
-
Figure Rheumatology Drugs Picture
-
Table Global Rheumatology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rheumatology Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Rheumatology Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Rheumatology Drugs Consumption by Country (2017-2022)
-
Figure United States Rheumatology Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Rheumatology Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Rheumatology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Rheumatology Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Rheumatology Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Rheumatology Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatology Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Rheumatology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Rheumatology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Rheumatology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Rheumatology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Rheumatology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Rheumatology Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Disease Modifying Anti-rheumatic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Nonsteroidal Anti-inflammatory Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroids Consumption and Growth Rate (2017-2022)
-
Figure Global Uric Acid Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)
-
Figure Global Disease Modifying Anti-rheumatic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nonsteroidal Anti-inflammatory Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Uric Acid Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Rheumatology Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Rheumatology Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Rheumatology Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Rheumatology Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Rheumatology Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Rheumatology Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Rheumatology Drugs Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Rheumatology Drugs Product and Service
-
Table Merck and Co (Foundation Year, Company Profile and etc.)
-
Table Merck and Co Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck and Co Rheumatology Drugs Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Rheumatology Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Rheumatology Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Rheumatology Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Rheumatology Drugs Product and Service
-
